电邮这篇文章 Ways to optimize the assessment of lean body mass in hemodialysis patients
- 作者: Lavrishcheva J.V.1, Jakovenko A.A.2
-
隶属关系:
- Almazov National Medical Research Centre of the Ministry of Healthcare of the Russian Federation
- Pavlov First Saint Petersburg State Medical University
- 期: 卷 9, 编号 1 (2019)
- 页面: 23-28
- 栏目: Original articles
- URL: https://ogarev-online.ru/uroved/article/view/11330
- DOI: https://doi.org/10.17816/uroved9123-28
- ID: 11330
如何引用文章
全文:
详细
The aim. To conduct a comparative analysis of the effectiveness of methods for assessing lean body mass in haemodialysis patients.
Patients and methods. A total of 317 patients receiving treatment with programmatic bicarbonate haemodialysis in 9 haemodialysis centers in 5 regions of the European part of the Russian Federation were examined for 8.2 ± 5.1 years, among them 171 women and 146 men, the average age was 57.1 ± 11.3 years. Dual-energy X-ray absorptiometry and bioimpedancemetry were used to assess lean body mass.
Results. The results of determining the total lean body mass obtained from the results of dual-energy X-ray absorptiometry and bioimpedancemetry were compared using the Bland-Altman method. The correlation coefficient between the indicators was r = 0.994, p < 0.0001, delta (M ± σ) was –0.48 ± 0.91 kg, CI 95% (–0.71)–(–0.26) kg.
Conclusion. Dual-energy X-ray absorptiometry has no significant advantages compared with bioimpedancemetry when evaluating lean body mass in haemodialysis patients.
作者简介
Juliia Lavrishcheva
Almazov National Medical Research Centre of the Ministry of Healthcare of the Russian Federation
编辑信件的主要联系方式.
Email: lavrischeva@gmail.com
Nephrologist
俄罗斯联邦, Saint PetersburgAleksandr Jakovenko
Pavlov First Saint Petersburg State Medical University
Email: leptin-rulit@mail.ru
Candidate of Medical Science, Associate Professor
俄罗斯联邦, Saint Petersburg参考
- Kittiskulnam P, Chertow GM, Carrero JJ, et al. Sarcopenia and its individual criteria are associated, in part, with mortality among patients on hemodialysis. Kidney Int. 2017;92(1):238-247. https://doi.org/10.1016/j.kint.2017.01.024.
- Giglio J, Kamimura MA, Lamarca F, et al. Association of Sarcopenia with Nutritional Parameters, Quality of Life, Hospitalization, and Mortality Rates of Elderly Patients on Hemodialysis. J Ren Nutr. 2018;28(3):197-207. https://doi.org/10.1053/j.jrn.2017.12.003.
- Bataille S, Serveaux M, Carreno E, et al. The diagnosis of sarcopenia is mainly driven by muscle mass in hemodialysis patients. Clin Nutr. 2017;36(6):1654-1660. https://doi.org/10.1016/j.clnu.2016.10.016.
- Messina C, Maffi G, Vitale JA, et al. Diagnostic imaging of osteoporosis and sarcopenia: a narrative review. Quant Imaging Med Surg. 2018;8(1):86-99. https://doi.org/10.21037/qims.2018.01.01.
- Battaglia Y, Galeano D, Cojocaru E, et al. Muscle-wasting in end stage renal disease in dialysis treatment: a review. G Ital Nefrol. 2016;33(2).
- Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39(4):412-423. https://doi.org/10.1093/ageing/afq034.
- Arias-Guillen M, Perez E, Herrera P, et al. Bioimpedance spectroscopy as a practical tool for the early detection and prevention of protein-energy wasting in hemodialysis patients. J Ren Nutr. 2018;28(5):324-332. https://doi.org/10.1053/j.jrn.2018.02.004.
- Guglielmi G, Ponti F, Agostini M, et al. The role of DXA in sarcopenia. Aging Clin Exp Res. 2016;28(6):1047-1060. https://doi.org/10.1007/s40520-016-0589-3.
- Popovic V, Zerahn B, Heaf JG. Comparison of dual energy X-ray absorptiometry and bioimpedance in assessing body composition and nutrition in peritoneal dialysis patients. J Ren Nutr. 2017;27(5):355-363. https://doi.org/10.1053/j.jrn.2017.03.003.
- Kittiskulnam P, Carrero JJ, Chertow GM, et al. Sarcopenia among patients receiving hemodialysis: weighing the evidence. J Cachexia Sarcopenia Muscle. 2017;8(1):57-68. https://doi.org/10.1002/jcsm.12130.
- Dehesa-Lopez E, Correa-Rotter R, Olvera-Castillo D, et al. Transcultural adaptation and validation of the Mexican version of the kidney disease questionnaire KDQOL-SF36 version 1.3. Qual Life Res. 2017;26(1):193-198. https://doi.org/10.1007/s11136-016-1365-8.
- Cao L, Morley JE. Sarcopenia is recognized as an independent condition by an international classification of disease, tenth revision, clinical modification (ICD-10-CM) Code. J Am Med Dir Assoc. 2016;17(8):675-677. https://doi.org/10.1016/j.jamda.2016.06.001.
补充文件
